United States · Wires & real time · PR Newswire

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Published by PR Newswire · United States 1 h ago

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on October 20, 2026 under the…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Business Wire

News Media Advisory: Absolute Security Demonstrates Autonomous Endpoint Resilience at SentinelOne OneCon 2026

Associated Press (Business)

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Dow Jones Newswires

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Share

Also worth reading

News Media Advisory: Absolute Security Demonstrates Autonomous Endpoint Resilience at SentinelOne OneCon 2026

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening